SHOW DIRECTORY
Moonshots
Conversations about exponential technologies, AI, longevity, space, robotics, and the entrepreneurs attempting unusually large missions.
BIDCLUB DESCRIPTION
Robotic Deep-Dive: Beating China, the Race Against Tesla, & New Robotics Timeline With Brett Adcock
Peter DiamandisDave BlundinBrett Adcock
Figure’s home launch depends on general intelligence that can sustain useful work for hours in unfamiliar homes, a capability Brett Adcock hopes to demonstrate in under six months but does not promise.Helix 2.5 shows improving execution as data grows, while Figure commits low nine figures annually to compute; commercial payoff still hinges on that trend holding.Figure 4 targets greater dexterity and home lease economics of $300–$500 monthly, while Baku’s potential 40,000-robot annual capacity remains contingent on solving intelligence.
Jensen’s Spy Probe, Anthropic’s Debut Week, and Elon’s 30M Robot Workforce | #310
Peter DiamandisDave BlundinAlexander Wissner-GrossEmad Mostaque
Unverified allegations involving Jensen Huang have put NVIDIA’s succession risk in focus; Dave Blundin says he sees no succession plan.NVIDIA’s reliance on TSMC and need to keep innovating make leadership continuity and manufacturing access key exposures.The investigation’s outcome remains uncertain, while national-security controls and Anthropic’s proposed IPO could reshape AI competition.
OpenAI Bulk-Solves 722 Math Problems, Anthropic’s Cruelty Policy, & Elon’s Quadrillion-Dollar SpaceX
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-Gross
OpenAI’s October 6 release of 722 math solutions signals automation in verifiable research; cryptography’s absence drew Alex’s post-quantum risk warning.Meta’s active memory and 3.6 billion daily users offer reach, but Alex says Muse trails on cost.Alex forecasts the $1.8 billion virtual-cell initiative could yield cures for 5,000 diseases within two to three years, pending FDA acceptance.
Astro Teller: The $1B Bet No CEO Will Back, Moonshots 3x Cheaper in 16 yrs, and Clean Water at 1¢/L
X says the cost of producing a graduate has fallen roughly threefold over 16 years, while its funnel yields only two graduates from up to 200 code-named ideas annually.Protected governance and early kill discipline make that portfolio economically plausible, but AI cannot replace human-led acceptance and distribution, while clean water still must reach roughly one cent per liter and industrialization remains 95% of the work.
Why We're Living in a Biological Singularity With Ben Lamm | MOONSHOTS Live #297
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossBen Lamm
Colossal is now worth over $10 billion with more than four spin-offs, while AI connects fragmented research and addresses 40–60% replication failure through standardized language.That data infrastructure may matter more than the model itself as comparative genomics spans thousands of genomes.Colossal has surpassed 300 edits at over 90% efficiency and is testing 1,000, with large-fragment DNA synthesis and a fully extrauterine mammalian birth within 24 months as catalysts amid ethical and regulatory constraints.
We Gave Away $2,000,000 To 5 AI Builders | MOONSHOTS Live
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossCathie Wood
Peter Diamandis says the education-to-employment contract is “done,” while Build with Gemini XPRIZE tests whether teams can build profitable companies around problems affecting 100,000 people in 90 days.Cathie Wood calls a one-person AI startup a career “call option” despite a 90% failure rate, and Logan Kilpatrick says data—not compute—now constrains progress, favoring unique datasets and domain expertise.
Palmer Luckey: Autonomous Weapons Are Ancient and Why Anduril Won't Build Humanoids | EP #295
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossPalmer Luckey
Anduril’s $2.2 million wildfire XPRIZE win, including $1 million from Lockheed, shows its autonomy workflow can transfer to emergencies where a 10-minute versus hour-long response requires different tools.Luckey’s specialized, verifiable systems and self-funded product model challenge a market where five companies once captured roughly 80% of major defense acquisition programs, while Anduril’s choice to use rather than build humanoids keeps platform scope and procurement scale in focus.
Ask the Mates Anything Round #2 | MOONSHOTS AMA #293
Peter DiamandisSalim IsmailDave BlundinDr. Alexander Wissner-Gross
AI’s next control layer may be machine-on-machine oversight, using readable activations and truthful real-world contexts.Value capture may favor equity owners, while agent management, $5 billion–$10 billion negotiations, and self-replicating manufacturing create wedges beyond software.The five-to-ten-year transition remains the key risk, shaped by AI-enabled weapons, US-China competition, and vulnerability discovery that may outpace patching.
Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030 | EP#290
Peter DiamandisMartine Rothblatt
United Therapeutics has four thymus shots on goal, including an FDA-approved xenothymus program and newly acquired Thymmune, making thymic replacement Rothblatt’s “most practical pathway” to LEV in the 2030s.Its xeno-kidney trial is mid-flight, facilities are slated for Rochester in August and Houston in October, and xeno-heart moved to Phase 3 after two patients survived 60 days without heart failure, with IVIVA trials starting in 2028.
Ask the Mates anything | MOONSHOTS AMA #289
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-Gross
Frontier labs are reportedly considering $5–$15 million checks for data-rich corporations, making packaging and access—not price—the binding constraint.Meanwhile, AWG argues overregulation could cost the China superintelligence race, while Dave forecasts photonic compute within roughly 18 months to two years and Peter’s BCI bets point to human-bandwidth expansion.









